FGF2 and neoplasm: Notably, in non‐responders, T1 tumor cells were engaged in an interplay with meCAFs via VEGFC–KDR signaling (kinase insert domain receptor; VEGF receptor 2) and exclusively received FGF2–FGFR1 signals from meCAFs (Figure 3F).